Literature DB >> 23190227

ERBB2 inhibition and heart failure.

Gregory M Cote1, Douglas B Sawyer, Bruce A Chabner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23190227     DOI: 10.1056/NEJMcibr1203156

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  34 in total

1.  Improving prediction of cardiovascular complications of cancer therapy: what does the future hold?

Authors:  Ana Barac
Journal:  Future Cardiol       Date:  2015-08-04

2.  A specified therapeutic window for neuregulin-1 to regenerate neonatal heart muscle.

Authors:  Federica Santoro; Makoto Sahara
Journal:  Ann Transl Med       Date:  2015-10

Review 3.  Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies.

Authors:  Tolulope A Agunbiade; Raja Y Zaghlol; Ana Barac
Journal:  Methodist Debakey Cardiovasc J       Date:  2019 Oct-Dec

4.  Regenerative biology: Neuregulin 1 makes heart muscle.

Authors:  Katherine E Yutzey
Journal:  Nature       Date:  2015-04-23       Impact factor: 49.962

5.  Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast Cancer.

Authors:  Anthony F Yu; Jasmeet C Singh; Rui Wang; Jennifer E Liu; Anne Eaton; Kevin C Oeffinger; Richard M Steingart; Clifford A Hudis; Chau T Dang
Journal:  Oncologist       Date:  2017-03-24

Review 6.  Cardiotoxicity due to Chemotherapy: the Role of Biomarkers.

Authors:  Patrick L Stevens; Daniel J Lenihan
Journal:  Curr Cardiol Rep       Date:  2015-07       Impact factor: 2.931

Review 7.  Heart regeneration with engineered myocardial tissue.

Authors:  Kareen L K Coulombe; Vivek K Bajpai; Stelios T Andreadis; Charles E Murry
Journal:  Annu Rev Biomed Eng       Date:  2014-04-24       Impact factor: 9.590

8.  Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based study.

Authors:  H-T Tsai; C Isaacs; A Z Fu; J L Warren; A N Freedman; A Barac; C-Y Huang; A L Potosky
Journal:  Breast Cancer Res Treat       Date:  2014-01-28       Impact factor: 4.872

9.  Administration of trastuzumab with heart irradiation induced acute cardiotoxicity in mice.

Authors:  Peiqiang Yi; Huan Li; Yuehua Fang; Jun Su; Cheng Xu; Lu Cao; Min Li; Jiayi Chen
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166

Review 10.  Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies.

Authors:  Naomi Dempsey; Amanda Rosenthal; Nitika Dabas; Yana Kropotova; Marc Lippman; Nanette H Bishopric
Journal:  Breast Cancer Res Treat       Date:  2021-06-11       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.